Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

584 Articles

Lee Jackson | Feb 6, 2015 at 10:10 AM EST

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

24/7 Wall St. reviewed the new Credit Suisse Top Picks for 2015 report, and here are five of the top…

Lee Jackson | Feb 5, 2015 at 10:00 AM EST

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the…

Lee Jackson | Dec 29, 2014 at 10:05 AM EST

5 Top Pharmaceutical Stock Picks for 2015

In a new research report, the SunTrust Robinson Humphrey team highlights the top pharmaceutical stocks to buy for 2015.

Jon C. Ogg | Nov 13, 2014 at 8:20 AM EST

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Thursday's top analyst upgrades, downgrades and initiations include Applied Materials, Broadcom, Cisco Systems, Genworth Financial and SanDisk.

Jon C. Ogg | Oct 16, 2014 at 8:20 AM EDT

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

These are the top analyst upgrades and downgrades featured by 24/7 Wall St. for Thursday, October 16, 2014.

Lee Jackson | Oct 2, 2014 at 8:55 AM EDT

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

The data is grim: cancer is increasing. Sales of these top oncology drugs are likely to increase as well.

Lee Jackson | Sep 29, 2014 at 8:30 AM EDT

3 Likely Biotech Buyout Candidates

A new research report from the analysts at Cowen sees a potential wave of biotech deals, some of which could…

Lee Jackson | Sep 3, 2014 at 10:45 AM EDT

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…

Chris Lange | Aug 21, 2014 at 2:44 PM EDT

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…

Jon C. Ogg | Jul 2, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…

Trey Thoelcke | Jun 11, 2014 at 10:15 AM EDT

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in…

Jon C. Ogg | Jun 5, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 5, 2014. They include Apple, Lululemon,…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 15, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Thursday, May 15, 2014. They include Cisco…

Trey Thoelcke | Apr 21, 2014 at 9:05 AM EDT

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off…

1 … 26 27 28 29 30 … 39

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

5 Top Pharmaceutical Stock Picks for 2015

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

3 Likely Biotech Buyout Candidates

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

5 Top Credit Suisse Health Care Stock Picks to Buy for 2015

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

5 Top Pharmaceutical Stock Picks for 2015

Top Analyst Upgrades and Downgrades: Applied Materials, Broadcom, Cisco, Genworth, SanDisk and More

Top Analyst Upgrades and Downgrades: AmEx, Baidu, BofA, Citi, Lululemon, Netflix, Tiffany and More

Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst

3 Likely Biotech Buyout Candidates

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

Why Affluent Couples Are Draining the Higher-Earning Spouse’s 401(k) First to Avoid the Widow’s Tax Penalty

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Featured Reads

Why Affluent Couples Are Draining the Higher-Earning Spouse's 401(k) First to Avoid the Widow's Tax Penalty

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It